{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:04:12Z","timestamp":1784070252721,"version":"3.55.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Radiology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jacr.2022.02.015","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T06:49:57Z","timestamp":1652165397000},"page":"S156-S174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S","title":["ACR Appropriateness Criteria\u00ae Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Carcinoma: 2021 Update"],"prefix":"10.1016","volume":"19","author":[{"given":"Andrei S.","family":"Purysko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Nikolaidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moises","family":"Auron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Diaz","family":"De Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhakshinamoorthy","family":"Ganeshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan T.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Shek-Man Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Lyshchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles T.","family":"Taffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don C.","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacr.2022.02.015_bib1","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jacr.2022.02.015_bib2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.6004\/jnccn.2017.0100","article-title":"Kidney cancer, version 2.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Motzer","year":"2017","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.jacr.2022.02.015_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.eururo.2019.04.026","article-title":"Oncologic outcomes following partial nephrectomy and percutaneous ablation for cT1 renal masses","volume":"76","author":"Andrews","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3348\/kjr.2018.19.5.938","article-title":"Efficacy and safety of microwave ablation for malignant renal tumors: an updated systematic review and meta-analysis of the literature since 2012","volume":"19","author":"Choi","year":"2018","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jacr.2022.02.015_bib5","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s00330-015-4006-7","article-title":"Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients","volume":"26","author":"Iannuccilli","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jacr.2022.02.015_bib6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00270-014-0846-9","article-title":"Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours","volume":"37","author":"Katsanos","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jacr.2022.02.015_bib7","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1148\/radiol.2020190919","article-title":"Percutaneous microwave ablation versus laparoscopic partial nephrectomy for cT1a renal cell carcinoma: a propensity-matched cohort study of 1955 patients","volume":"294","author":"Yu","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2022.02.015_bib8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/cncr.26369","article-title":"Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis","volume":"118","author":"Smaldone","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jacr.2022.02.015_bib9","first-page":"407","article-title":"Follow-up for clinically localized renal neoplasms: AUA guideline","volume":"190","author":"Donat","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.clgc.2018.11.009","article-title":"Capturing renal cell carcinoma recurrences when asymptomatic improves patient survival","volume":"17","author":"Merrill","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.jacr.2022.02.015_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","article-title":"European Association of Urology guidelines on renal cell carcinoma: the 2019 update","volume":"75","author":"Ljungberg","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bju.13384","article-title":"Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma","volume":"117","author":"Williamson","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2022.02.015_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.eururo.2018.10.007","article-title":"Intensive imaging-based follow-up of surgically treated localised renal cell carcinoma does not improve post-recurrence survival: results from a European Multicentre Database (RECUR)","volume":"75","author":"Dabestani","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/iju.12962","article-title":"Features, risk factors and clinical outcome of \u201cvery late\u201d recurrences after surgery for localized renal carcinoma: a retrospective evaluation of a cohort with a minimum of 10 years of follow up","volume":"23","author":"Antonelli","year":"2016","journal-title":"Int J Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib15","first-page":"1163","article-title":"Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma","volume":"159","author":"Levy","year":"1998","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2019.10.004","article-title":"Renal fossa recurrence after radical nephrectomy: current management, and oncological outcomes","volume":"38","author":"Romeo","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jacr.2022.02.015_bib17","first-page":"58","article-title":"Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy","volume":"172","author":"Stephenson","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib18","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1200\/JCO.2015.61.8009","article-title":"Oncologic surveillance after surgical resection for renal cell carcinoma: a novel risk-based approach","volume":"33","author":"Stewart-Merrill","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jacr.2022.02.015_bib19","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1200\/JCO.2002.05.111","article-title":"Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma","volume":"20","author":"Zisman","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jacr.2022.02.015_bib20","first-page":"322","article-title":"Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy","volume":"164","author":"Itano","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib21","first-page":"28","article-title":"A\u00a0new protocol for the followup of renal cell carcinoma based on pathological stage","volume":"154","author":"Sandock","year":"1995","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib22","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0090-4295(98)00423-3","article-title":"Radiologic follow-up of patients with T1-3a,b,c or T4N+M0 renal cell carcinoma after radical nephrectomy","volume":"52","author":"Saidi","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2022.02.015_bib23","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.4065\/75.12.1236","article-title":"Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney","volume":"75","author":"Lau","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacr.2022.02.015_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.urology.2018.08.038","article-title":"Should we separate the pulmonary surveillance protocol for postsurgical T1a and T1b renal cell carcinoma? A multicenter database analysis","volume":"122","author":"Chow","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2022.02.015_bib25","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2214\/AJR.17.18898","article-title":"Utility of pelvic CT for surveillance of T2-T4 renal cell carcinoma after nephrectomy with curative intent","volume":"210","author":"Kaiser","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2022.02.015_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/RCT.0000000000000841","article-title":"Is chest computed tomography always necessary following nephrectomy for renal cell carcinoma? A pilot study in single tertiary institution","volume":"43","author":"Lee","year":"2019","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.jacr.2022.02.015_bib27","first-page":"321","article-title":"The usefulness of chest X-rays for T1a renal cell carcinoma surveillance","volume":"196","author":"Canvasser","year":"2016","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib28","first-page":"1015","article-title":"Chest X-ray in the follow-up of renal cell carcinoma","volume":"32","author":"Doornweerd","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib29","first-page":"1680","article-title":"Use of surveillance imaging following treatment of small renal masses","volume":"190","author":"Kowalczyk","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib30","first-page":"2067","article-title":"Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma","volume":"157","author":"Hafez","year":"1997","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib31","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.crad.2011.06.002","article-title":"Is dual-phase abdominal CT necessary for the optimal detection of metastases from renal cell carcinoma?","volume":"66","author":"Jain","year":"2011","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jacr.2022.02.015_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2018.08.006","article-title":"Abbreviated CT protocol for postoperative surveillance of renal cancer","volume":"36","author":"Gofrit","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jacr.2022.02.015_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2214\/ajr.172.1.9888732","article-title":"Staging of 119 patients with renal cell carcinoma: the yield and cost-effectiveness of pelvic CT","volume":"172","author":"Fielding","year":"1999","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2022.02.015_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1014432331201","article-title":"Is there a need for pelvic CT scan in cases of renal cell carcinoma?","volume":"33","author":"Khaitan","year":"2002","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jacr.2022.02.015_bib35","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1007\/s00261-018-1541-0","article-title":"Imaging following renal ablation: what can we learn from recurrent tumors?","volume":"43","author":"Eiken","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jacr.2022.02.015_bib36","doi-asserted-by":"crossref","first-page":"660.e1","DOI":"10.1016\/j.urolonc.2017.06.052","article-title":"Imaging strategy and outcome following partial nephrectomy","volume":"35","author":"Mouracade","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jacr.2022.02.015_bib37","first-page":"1888","article-title":"Tumor infiltrated hilar and mediastinal lymph nodes are an independent prognostic factor for decreased survival after pulmonary metastasectomy in patients with renal cell carcinoma","volume":"184","author":"Winter","year":"2010","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib38","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3109\/02841851003724846","article-title":"Whole-body MRI in follow-up of patients with renal cell carcinoma","volume":"51","author":"Platzek","year":"2010","journal-title":"Acta Radiol"},{"key":"10.1016\/j.jacr.2022.02.015_bib39","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s11255-019-02141-1","article-title":"Magnetic resonance imaging characteristics and changes in hemostatic agents after partial nephrectomy","volume":"51","author":"Kisa","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jacr.2022.02.015_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000499299","article-title":"Renal Cell Carcinoma follow-up\u2014is it time to abandon ultrasound?","volume":"13","author":"Quinlan","year":"2019","journal-title":"Curr Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.carj.2019.06.011","article-title":"Negative predictive value of contrast-enhanced ultrasound of liver and kidney thermal ablation sites for local tumour progression during long-term follow-up: a retrospective consecutive study","volume":"70","author":"Atri","year":"2019","journal-title":"Can Assoc Radiol J"},{"key":"10.1016\/j.jacr.2022.02.015_bib42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1089\/end.2012.0400","article-title":"Contrast-enhanced ultrasound for the evaluation of the cryolesion after laparoscopic renal cryoablation: an initial report","volume":"27","author":"Barwari","year":"2013","journal-title":"J\u00a0Endourol"},{"key":"10.1016\/j.jacr.2022.02.015_bib43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.urology.2018.05.053","article-title":"Long term surveillance of renal cell carcinoma recurrence following ablation using 2D and 3D contrast-enhanced ultrasound","volume":"121","author":"Calio","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2022.02.015_bib44","first-page":"685","article-title":"Contrast-enhanced ultrasound for assessment of therapeutic response after percutaneous radiofrequency ablation of small renal tumors","volume":"21","author":"Garbajs","year":"2016","journal-title":"J\u00a0BUON"},{"key":"10.1016\/j.jacr.2022.02.015_bib45","doi-asserted-by":"crossref","first-page":"20190183","DOI":"10.1259\/bjr.20190183","article-title":"Clinical application of contrast-enhanced ultrasound after percutaneous renal tumor ablation","volume":"92","author":"Guo","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jacr.2022.02.015_bib46","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1007\/s00330-010-1742-6","article-title":"Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour","volume":"20","author":"Hoeffel","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jacr.2022.02.015_bib47","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00261-010-9665-x","article-title":"Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?","volume":"36","author":"Kong","year":"2011","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.jacr.2022.02.015_bib48","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11934-014-0469-3","article-title":"Contrast-enhanced ultrasound (CEUS): an excellent tool in the follow-up of small renal masses treated with cryoablation","volume":"16","author":"Sanz","year":"2015","journal-title":"Curr Urol Rep"},{"issue":"Suppl 23","key":"10.1016\/j.jacr.2022.02.015_bib49","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.5301\/RU.2014.11986","article-title":"Comparison of contrast-enhanced ultrasound scan (CEUS) and MRI in the follow-up of cryoablation for small renal tumors. Experience on 25 cases","volume":"81","author":"Zeccolini","year":"2014","journal-title":"Urologia"},{"key":"10.1016\/j.jacr.2022.02.015_bib50","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0090-4295(85)90148-7","article-title":"Value of routine radionuclide bone scans in renal cell carcinoma","volume":"26","author":"Blacher","year":"1985","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2022.02.015_bib51","first-page":"2126","article-title":"The diagnostic value of bone scan in patients with renal cell carcinoma","volume":"166","author":"Koga","year":"2001","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MNM.0000000000000618","article-title":"Diagnostic performance of 18F-FDG PET or PET\/CT in restaging renal cell carcinoma: a systematic review and meta-analysis","volume":"38","author":"Ma","year":"2017","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.jacr.2022.02.015_bib53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5603\/NMR.2018.0024","article-title":"Diagnostic value of F-18 FDG PET\/CT for local and distant disease relapse surveillance in surgically treated RCC patients: can it aid in establishing consensus follow up strategy?","volume":"21","author":"Elahmadawy","year":"2018","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"10.1016\/j.jacr.2022.02.015_bib54","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s12149-018-1287-3","article-title":"Diagnostic performance of (11)C-choline PET\/CT and FDG PET\/CT for staging and restaging of renal cell cancer","volume":"32","author":"Nakanishi","year":"2018","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.jacr.2022.02.015_bib55","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/annonc\/mdv289","article-title":"Prospective study evaluating the relative sensitivity of 18F-NaF PET\/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design","volume":"26","author":"Gerety","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jacr.2022.02.015_bib56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00259-016-3360-2","article-title":"Diagnostic potential of PET\/CT using a 68Ga-labelled prostate-specific membrane antigen ligand in whole-body staging of renal cell carcinoma: initial experience","volume":"44","author":"Sawicki","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jacr.2022.02.015_bib57","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1089\/end.2010.0067","article-title":"Comparison of percutaneous and laparoscopic renal cryoablation for small (<3.0 cm) renal masses","volume":"24","author":"Mues","year":"2010","journal-title":"J\u00a0Endourol"},{"key":"10.1016\/j.jacr.2022.02.015_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.acra.2010.08.006","article-title":"Cryoablation vs. radiofrequency ablation for small renal masses","volume":"18","author":"Pirasteh","year":"2011","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jacr.2022.02.015_bib59","first-page":"1177","article-title":"Comparison of safety, renal function outcomes and efficacy of laparoscopic and percutaneous radio frequency ablation of renal masses","volume":"187","author":"Young","year":"2012","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib60","first-page":"889","article-title":"Laparoscopic renal cryoablation: 8-year, single surgeon outcomes","volume":"183","author":"Aron","year":"2010","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib61","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00330-013-2784-3","article-title":"Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients","volume":"23","author":"Balageas","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jacr.2022.02.015_bib62","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/bju.12122","article-title":"Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients","volume":"112","author":"Breen","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2022.02.015_bib63","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s00270-013-0831-8","article-title":"Efficacy and safety of percutaneous cryoablation for stage 1A\/B renal cell carcinoma: results of a prospective, single-arm, 5-year study","volume":"37","author":"Georgiades","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jacr.2022.02.015_bib64","first-page":"61","article-title":"Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent","volume":"174","author":"McDougal","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib65","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.urology.2019.09.024","article-title":"Comparing outcomes for patients with clinical T1b renal cell carcinoma treated with either percutaneous microwave ablation or surgery","volume":"135","author":"Shapiro","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2022.02.015_bib66","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/bju.12349","article-title":"Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours","volume":"113","author":"Wah","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2022.02.015_bib67","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.urology.2010.12.077","article-title":"Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma","volume":"77","author":"Zagoria","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2022.02.015_bib68","first-page":"1183","article-title":"Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters","volume":"187","author":"Best","year":"2012","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib69","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jvir.2009.12.400","article-title":"Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors","volume":"21","author":"Javadi","year":"2010","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jacr.2022.02.015_bib70","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1089\/end.2015.0405","article-title":"Computed tomography contrast enhancement following renal cryoablation\u2014does it represent treatment failure?","volume":"29","author":"Nielsen","year":"2015","journal-title":"J\u00a0Endourol"},{"key":"10.1016\/j.jacr.2022.02.015_bib71","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.ejrad.2013.11.022","article-title":"Dual-energy CT in assessing therapeutic response to radiofrequency ablation of renal cell carcinomas","volume":"83","author":"Park","year":"2014","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jacr.2022.02.015_bib72","doi-asserted-by":"crossref","first-page":"20160151","DOI":"10.1259\/bjr.20160151","article-title":"Evolutionary magnetic resonance appearance of renal cell carcinoma after percutaneous cryoablation","volume":"89","author":"Lee","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jacr.2022.02.015_bib73","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2214\/AJR.15.14821","article-title":"False-positive tumor enhancement after cryoablation of renal cell carcinoma: a prospective study","volume":"206","author":"Takaki","year":"2016","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2022.02.015_bib74","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2214\/AJR.09.2518","article-title":"MRI after technically successful renal cryoablation: early contrast enhancement as a common finding","volume":"194","author":"Porter","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2022.02.015_bib75","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/iju.12734","article-title":"Active surveillance for clinically localized renal tumors: an updated review of current indications and clinical outcomes","volume":"22","author":"Borghesi","year":"2015","journal-title":"Int J Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib76","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.eururo.2011.02.023","article-title":"Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance","volume":"59","author":"Mason","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib77","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1464-410X.2012.11130.x","article-title":"Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy","volume":"110","author":"Patel","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2022.02.015_bib78","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.eururo.2015.02.001","article-title":"Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry","volume":"68","author":"Pierorazio","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib79","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.eururo.2011.06.040","article-title":"Treatment of localised renal cell carcinoma","volume":"60","author":"Van Poppel","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib80","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1464-410X.2012.10969.x","article-title":"Evolving practice patterns for the management of small renal masses in the USA","volume":"110","author":"Yang","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2022.02.015_bib81","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.urology.2010.09.031","article-title":"Natural history of renal cortical neoplasms during active surveillance with follow-up longer than 5 years","volume":"77","author":"Haramis","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2022.02.015_bib82","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/RCT.0000000000000407","article-title":"Active surveillance of small renal masses: a review on the role of imaging with a focus on growth rate","volume":"40","author":"Nayyar","year":"2016","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.jacr.2022.02.015_bib83","doi-asserted-by":"crossref","first-page":"74.e13","DOI":"10.1016\/j.urolonc.2019.11.008","article-title":"Delayed nephrectomy has comparable long-term overall survival to immediate nephrectomy for cT1a renal cell carcinoma: a population-based analysis","volume":"38","author":"Tan","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jacr.2022.02.015_bib84","first-page":"641","article-title":"Growth kinetics of small renal masses on active surveillance: variability and results from the DISSRM Registry","volume":"199","author":"Uzosike","year":"2018","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2022.02.015_bib85","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.urology.2019.08.043","article-title":"Renal mass biopsy is associated with reduction in surgery for early-stage kidney cancer","volume":"135","author":"Patel","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2022.02.015_bib86","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2214\/AJR.14.13227","article-title":"MRI features of renal cell carcinoma that predict favorable clinicopathologic outcomes","volume":"204","author":"Doshi","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2022.02.015_bib87","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2214\/AJR.11.7735","article-title":"Comparison of CT-based methodologies for detection of growth of solid renal masses on active surveillance","volume":"199","author":"Rosenkrantz","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2022.02.015_bib88","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2214\/AJR.07.3546","article-title":"Comparison of contrast-enhanced sonography with unenhanced sonography and contrast-enhanced CT in the diagnosis of malignancy in complex cystic renal masses","volume":"191","author":"Quaia","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2022.02.015_bib89","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1148\/radiol.13130161","article-title":"Evaluation of indeterminate renal masses with contrast-enhanced US: a diagnostic performance study","volume":"271","author":"Barr","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2022.02.015_bib90","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/jum.14208","article-title":"Contrast-enhanced ultrasound classification of previously indeterminate renal lesions","volume":"36","author":"Zarzour","year":"2017","journal-title":"J\u00a0Ultrasound Med"}],"container-title":["Journal of the American College of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144022001855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144022001855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:27:16Z","timestamp":1761546436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1546144022001855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":90,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1546144022001855"],"URL":"https:\/\/doi.org\/10.1016\/j.jacr.2022.02.015","relation":{},"ISSN":["1546-1440"],"issn-type":[{"value":"1546-1440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACR Appropriateness Criteria\u00ae Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Carcinoma: 2021 Update","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacr.2022.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Radiology","name":"copyright","label":"Copyright"}]}}